Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exact Sciences Cor
(NQ:
EXAS
)
49.84
-4.24 (-7.84%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Cor
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Market Pulls Back After Several Weeks Of Gains: Weekly Review
June 23, 2023
But the major indexes and leading stocks generally showed healthy action.
Via
Investor's Business Daily
Analysts Bullish On Exact Sciences' Advanced Cancer Screening
June 23, 2023
Exact Sciences sees a bump in stock price amid rising revenue and study results that show advancements to its flagship Cologuard colorectal screening product.
Via
MarketBeat
Exact Sciences Set To Dominate Emerging Precision Oncology Market: Analyst Applauds $18B Potential Market
June 22, 2023
Benchmark analyst Bruce D.
Via
Benzinga
2 Stocks to Invest $500 In and Hold For 10 Years
June 22, 2023
Both companies have outperformed the market over the past year.
Via
The Motley Fool
Exact Sciences Stock Is Trading Higher: What's Going On?
June 21, 2023
Exact Sciences Corp (NASDAQ: EXAS) shares are trading higher Wednesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for
Via
Benzinga
What 8 Analyst Ratings Have To Say About Exact Sciences
June 07, 2023
Via
Benzinga
1 Unstoppable Growth Stock to Buy and Hold for 10 Years
June 07, 2023
This company is finding success in fighting one of the deadliest illnesses.
Via
The Motley Fool
Why Exact Sciences Stock Roared Higher This Week
May 11, 2023
The cancer diagnostic company's Q1 report was full of good news for shareholders.
Via
The Motley Fool
Why Exact Sciences Stock Is Moving Higher After Hours
June 20, 2023
Exact Sciences Corp (NASDAQ: EXAS) shares are rising in extended trading Tuesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for
Via
Benzinga
Why Exact Sciences Stock With 219% Growth Could Surge Again
June 20, 2023
The company is trying to top its own success in colon cancer screening.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
June 20, 2023
Via
Benzinga
3 Revolutionary Companies With Trillion-Dollar Potential
June 14, 2023
These are just a few of the trillion-dollar potential companies to put on your radar screen for the second half.
Via
InvestorPlace
This Analyst With 87% Accuracy Rate Sees Around 16% Upside In Home Depot - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
June 12, 2023
The S&P 500 settled higher on Friday, surpassing the 4,300 level for the first time since August. The index also recorded gains for four weeks in a row.
Via
Benzinga
Expert Ratings for Exact Sciences
May 11, 2023
Via
Benzinga
Why Shares of Exact Sciences Rose on Wednesday
May 10, 2023
The diagnostic testing company announced strong first-quarter earnings.
Via
The Motley Fool
Exact Sciences (EXAS) Q1 2023 Earnings Call Transcript
May 09, 2023
EXAS earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Why Top 2% Stock Exact Sciences Is On An Eight-Month Hot Streak — And Nearing A Profit-Taking Zone
June 08, 2023
The colon cancer screening market is vast, and underserved. Exact Sciences wants to change that.
Via
Investor's Business Daily
Cathie Wood Is Buying the SEC Lawsuit Dip in Coinbase (COIN) Stock
June 07, 2023
Coinbase and the crypto industry at large is at war with regulators. But Cathie Wood is still buying shares of COIN stock.
Via
InvestorPlace
Cathie Wood Onto 'Next Thing' In AI After ARK's Nvidia Exit: What's On Her Radar?
May 31, 2023
Via
Benzinga
3 High-Flying Cathie Wood Stocks That Are Up Over 50% This Year
May 25, 2023
Is it too late to buy these rebounding stocks?
Via
The Motley Fool
MarketBeat Week in Review – 5/15 - 5/19
May 20, 2023
Investors are battling stagflation as they wait for a recession, and the MarketBeat team continues to help you understand where to find opportunities
Via
MarketBeat
Topics
Economy
Electric Vehicles
Exposures
Economy
Electric Vehicles
Interest Rates
3 AI Stocks That Famed Investor Cathie Wood Is Betting On
May 16, 2023
Exact Sciences will look to leverage AI to revolutionize its industry. Here are some other Cathie Wood AI stocks to consider too.
Via
InvestorPlace
Exact Sciences Serves Investors Exactly What They Wished For
May 15, 2023
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The
Via
MarketBeat
3 Personalized Medicine Stocks to Buy for Long-Time Returns
May 15, 2023
Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out.
Via
InvestorPlace
A Bull Market Is Coming: 1 Supercharged Growth Stock to Buy Hand Over Fist Before It Soars 164%, According to Wall Street
May 14, 2023
This stock has been crushed by macroeconomic headwinds but could rebound big time if analysts are right.
Via
The Motley Fool
Cathie Wood's Flagship ARK ETF Marks 5-Day Winning Streak — Outperforming Nasdaq, FAANG In May
May 11, 2023
Cathie Wood's flagship fund Ark Innovation ETF (ARCA: ARKK) marked a five-day winning streak on Wednesday for the first time since January, as a lower-than-expected U.S.
Via
Benzinga
Exact Sciences Guidance Beat Street View, Analyst Says Company Fires All Cylinders
May 10, 2023
Exact Sciences Corp's (NASDAQ: EXAS) Q1 revenues increased 24% Y/Y to $602 million, beating the average Wall Street esti
Via
Benzinga
Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday
May 10, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
May 10, 2023
Via
Benzinga
A New Groundbreaking Tool to Detect Colon Cancer Earlier
May 10, 2023
A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This...
Via
PressReach
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.